AUB appoints its 16th president, Fadlo R. Khuri, MD

fadlo khuri inThe Board of Trustees at the American University of Beirut has voted to elect Fadlo R. Khuri, MD, as the 16th president of the university. Dr. Khuri is presently Professor and Chairman of the Department of Hematology and Medical Oncology, Emory University School of Medicine, and holds the Roberto C. Goizueta Distinguished Chair for Cancer Research. He also serves as Deputy Director for the Winship Cancer Institute of Emory University. Dr. Khuri was recently appointed Executive Associate Dean for Research of the Emory University School of Medicine.

An AUB trustee since 2014 and AUB former student, he has been a member of Naef K. Basile Foundation Board of Trustees since 2005, and a member of the Atlanta International School Board of Trustees since 2009. Dr. Khuri has chaired the AUB Medical School International Advisory Committee since 2010. He currently serves as chair of the education committee of the Atlanta International School board of trustees.

He will be installed as the successor to Dr. Peter Dorman, who has served AUB with distinction since his appointment in March 2008.

The announcement today follows an intensive international search commissioned by the AUB Board of Trustees that included direct input from AUB faculty, students and staff and from worldwide alumni communities.

AUB Board Chairman Dr. Philip S. Khoury, who co-chaired the search committee with Trustee Dr. Huda Zoghbi, said, “The committee was particularly attentive to the needs of the university as defined by its own constituents. We found great consistency in the attributes AUB students, faculty, alumni, and other stakeholders identified as critical for the university’s leadership and we are completely confident that Dr. Khuri embodies those attributes.”

Read more

Conference & Events

GCC & MENA

HigherEd News

User Access

About Us

Follow Us

×

Sign up to keep in touch!

Be the first to hear about latest News in higher education from ArabiaHighered.

Check out our Privacy Policy & Terms of use
You can unsubscribe from email list at any time